3-(Bromomethyl)pyridazine

Catalog No.: 
ACTAHX519
CAS No.: 
60023-36-1
Molecular Formula: 
C5H5BrN2
Molecular Weight: 
173.01
3-(Bromomethyl)pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$145.00InquiryInquiry
1g98%$416.00InquiryInquiry
5g98%$1651.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Bromomethyl)pyridazine
IUPAC Name3-(Bromomethyl)pyridazine
MDL No.MFCD05664655
Molecular FormulaC5H5BrN2
Molecular Weight173.01
SMILESBrCC1=NN=CC=C1
InChI KeyCEBUNOCBCPXDNP-UHFFFAOYSA-N
Synonym3-(Bromomethyl)pyridazine;Pyridazine, 3-(bromomethyl)- (9CI);3-(Bormomethyl)pyridazine;3-(bromomethyl)pyridazine hydrochloride;Pyridazine, 3-(bromomethyl)-HBr;3-(BroMoMethyl)Pyridazine HBr;Pyridazine, 3-(bromomethyl)-;3-(BROMOMETHYL)PYRIDAZINE, ISO 9001:2015 REACH
CAS No.60023-36-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACTAHX519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFNQ542 route compound structure diagram
    ACUFNQ5421632-76-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTAHX519 route product structure diagram
    ACTAHX51960023-36-1
Inquiry

2. ACTAHX519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTWVG652 route compound structure diagram
    ACTWVG65237444-46-5In Stock
  4. Then
  5. ACTAHX519 route product structure diagram
    ACTAHX51960023-36-1
Inquiry

3. ACTAHX519 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTAHX519 route product structure diagram
    ACTAHX51960023-36-1
Inquiry

Comments (0)